Clinical Trial Update: IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intensity-modulated radiotherapy (IMRT) with lobaplatin-based concurrent chemoradiation for nasopharyngeal carcinoma; recruitment is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Lobaplatin (lobaplatin)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Nasopharyngeal Neoplasms, Elderly | Phase 2 | Status: ENROLLING_BY_INVITATION